Henry Schein’s (HSIC) “Outperform” Rating Reiterated at Barrington Research

Barrington Research restated their outperform rating on shares of Henry Schein (NASDAQ:HSIC) in a research note released on Wednesday,Benzinga reports. The firm currently has a $90.00 price target on the stock. Barrington Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.04 EPS, Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.28 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.22 EPS and FY2027 earnings at $5.65 EPS.

HSIC has been the subject of several other research reports. Jefferies Financial Group raised their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Mizuho began coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Up 0.1 %

HSIC stock opened at $72.17 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.00 billion, a price-to-earnings ratio of 29.70, a PEG ratio of 2.13 and a beta of 0.91. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The stock has a fifty day moving average of $74.35 and a 200-day moving average of $72.42.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 EPS. As a group, equities research analysts predict that Henry Schein will post 4.74 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Clarkston Capital Partners LLC grew its holdings in shares of Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Nuance Investments LLC lifted its position in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after buying an additional 414,748 shares during the last quarter. Olstein Capital Management L.P. lifted its position in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after buying an additional 16,000 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Henry Schein in the 3rd quarter worth approximately $515,000. Finally, Equitable Trust Co. bought a new stake in Henry Schein in the 4th quarter worth approximately $417,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.